VRNA vs. OKLO

Last updated Jun 13, 2026

VRNA (Verona Pharma plc) and OKLO (Oklo Inc.) are both stocks. VRNA operates in Biotechnology (Healthcare), while OKLO operates in Utilities - Independent Power Producers (Utilities). At a 0.08 correlation, their price movements are largely independent.

Performance

VRNA vs. OKLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Oklo Inc. (OKLO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

OKLO

• 1D: -0.64%
• 1M: -17.47%
• YTD: -19.89%
• 6M: -34.24%
• 1Y: -10.84%
• 3Y*: 75.64%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. OKLO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	18.10%
OKLO Oklo Inc.	-19.89%	238.01%	101.04%	6.45%	0.71%	-1.50%

Correlation

The correlation between VRNA and OKLO is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (All Time) Calculated using the full available price history since Jul 8, 2021	0.08

The correlation between VRNA and OKLO shifts across timeframes, from -0.04 (1 year) to 0.09 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VRNA : $9.72B OKLO : $9.79B
EPS VRNA : -$0.69 OKLO : -$0.85
PB Ratio VRNA : 34.92 OKLO : 3.71
Total Revenue (TTM) VRNA : $167.65M OKLO : $0.00
Gross Profit (TTM) VRNA : $159.52M OKLO : -$149.00K
EBITDA (TTM) VRNA : -$40.86M OKLO : -$172.42M

Return for Risk

VRNA vs. OKLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

OKLO

OKLO Risk / Return Rank: 41
OKLO Sharpe Ratio Rank: 39
OKLO Sortino Ratio Rank: 46
OKLO Omega Ratio Rank: 44
OKLO Calmar Ratio Rank: 39
OKLO Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. OKLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Oklo Inc. (OKLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VRNA	OKLO	Difference
Sharpe ratio: Return per unit of total volatility	—	-0.11	—
Sortino ratio: Return per unit of downside risk	—	0.60	—
Omega ratio: Gain probability vs. loss probability	—	1.06	—
Calmar ratio: Return relative to maximum drawdown	—	-0.15	—
Martin ratio: Return relative to average drawdown	—	-0.24	—

Drawdowns

Drawdown Indicators

	VRNA	OKLO	Difference
Max Drawdown Largest peak-to-trough decline	—	-73.83%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-73.83%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-73.83%	—
Current Drawdown Current decline from peak	—	-66.99%	—
Average Drawdown Average peak-to-trough decline	—	-18.13%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	45.70%	—

Volatility

Volatility by Period

	VRNA	OKLO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	27.86%	—
Volatility (6M) Calculated over the trailing 6-month period	—	69.66%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	101.88%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	85.88%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	85.88%	—

Dividends

VRNA vs. OKLO - Dividend Comparison

Neither VRNA nor OKLO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VRNA and OKLO in my portfolio?

VRNA and OKLO have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.